Related Experiment Video
Updated: Apr 7, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Prenatal exposure to systemic antibacterials and overweight and obesity in Danish schoolchildren: a prevalence study
A Mor1, S Antonsen1, J Kahlert1
1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Insights
Prenatal exposure to antibacterials is linked to a higher risk of overweight and obesity in children. This association was observed in schoolchildren and varied based on birth weight.
Area of Science:
- Reproductive Health
- Pediatric Health
- Metabolic Disorders
Background:
- Prenatal exposure to antibacterials may impact fetal development through epigenetic changes or altered maternal microbiota.
- Systemic antibacterial use during pregnancy raises concerns about long-term metabolic health in offspring.
Purpose of the Study:
- To investigate the association between prenatal exposure to systemic antibacterials and the risk of overweight and obesity in schoolchildren.
- To explore how birth weight modifies this association.
Main Methods:
- A prevalence study utilizing data from Danish schoolchildren aged 7-16 years (2002-2013).
- Prenatal antibacterial exposure was identified through maternal prescription records and infection-related hospitalizations.
- Overweight and obesity were defined using standard age- and sex-specific criteria; analyses were adjusted for covariates and stratified by birth weight.
Main Results:
- Prenatal antibacterial exposure was associated with increased prevalence ratios for overweight (1.26) and obesity (1.29) in schoolchildren.
- Associations differed between sexes and were influenced by birth weight, with distinct patterns for overweight and obesity relative to birth weight thresholds.
Conclusions:
- Prenatal exposure to systemic antibacterials is associated with an elevated risk of overweight and obesity in school-aged children.
- The relationship between prenatal antibacterial exposure and childhood overweight/obesity is moderated by birth weight.
Background/Objective:
Prenatal exposure to antibacterials may permanently dysregulate fetal metabolic patterns via epigenetic pathways or by altering maternal microbiota. We examined the association of prenatal exposure to systemic antibacterials with overweight and obesity in schoolchildren.
Subjects/Methods:
We conducted a prevalence study among Danish schoolchildren aged 7-16 years using data from routine school anthropometric evaluations conducted during 2002-2013. Prenatal exposure to antibacterials was ascertained by using maternal prescription dispensations and infection-related hospital admissions during pregnancy. We defined overweight and obesity among the children using standard age- and sex-specific cutoffs. We computed sex-specific adjusted prevalence ratios (aPRs) of overweight and obesity associated with exposure to prenatal antibacterials, adjusting for maternal age at delivery, marital status, smoking in pregnancy and multiple gestation; we also stratified the analyses by birth weight.
Results:
Among 9886 schoolchildren, 3280 (33%) had prenatal exposure to antibacterials. aPRs associated with the exposure were 1.26 (95% confidence interval (CI): 1.10-1.45) for overweight and 1.29 (95% CI: 1.03-1.62) for obesity. Among girls, aPRs were 1.16 (95% CI: 0.95-1.42) for overweight and 1.27 (95% CI: 0.89 to 1.82) for obesity. Among boys, aPRs were 1.37 (95% CI: 1.13-1.66) for overweight and 1.29 (95% CI: 0.96-1.73) for obesity. The aPR for overweight was higher among schoolchildren with birth weight <3500 g (aPR: 1.30, 95% CI: 1.05-1.61) than in schoolchildren with birth weight ⩾3500 g (aPR: 1.18, 95% CI: 0.95-1.46). Inversely, the association for obesity was higher among schoolchildren with birth weight ⩾3500 g (aPR: 1.35, 95% CI: 1.00-1.81) than among those who were <3500 g at birth (aPR: 1.16, 95% CI: 0.82-1.65).
Conclusions:
Prenatal exposure to systemic antibacterials is associated with an increased risk of overweight and obesity at school age, and this association varies by birth weight.
Related Concept Videos
Drug Dosing: Obese Patients
Development of Human Microbiota
Development of the Oral Microbiota
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity

